Onco-Move and OnTrack resulted in less decline in cardiorespiratory fitness ( P < @ ) , better physical functioning ( P @ ) , less nausea and vomiting ( P = @ and @ , respectively ) and less pain ( P = @ and @ , respectively ) compared with UC .